Company Filing History:
Years Active: 2002-2006
Title: The Innovative Contributions of Masaharu Shiotani
Introduction
Masaharu Shiotani is a prominent inventor based in Yokohama, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target lipid metabolism. With a total of six patents to his name, Shiotani's work is recognized for its potential impact on treating hyperlipidemia and arteriosclerotic diseases.
Latest Patents
Shiotani's latest patents include innovative nitrogen-containing heterocyclic compounds and benzamide compounds. These compounds are designed to inhibit triglyceride biosynthesis in the liver and reduce the secretion of apolipoprotein B-containing lipoproteins. The compounds are notable for their effectiveness without the side effect of lipid accumulation in the liver, making them valuable for the treatment and prevention of various metabolic disorders.
Career Highlights
Throughout his career, Masaharu Shiotani has been associated with Meiji Seika Kaisha, Ltd., a company known for its commitment to research and development in the pharmaceutical industry. His work has contributed to advancements in drug formulations and therapeutic strategies.
Collaborations
Shiotani has collaborated with notable colleagues, including Naoto Ohkura and Yukiko Hiraiwa. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Masaharu Shiotani's contributions to pharmaceutical innovation highlight the importance of research in developing effective treatments for metabolic diseases. His work continues to influence the field and offers hope for improved health outcomes.